首页 | 本学科首页   官方微博 | 高级检索  
     

抗人喉癌双功能抗体制备及对Hep-2细胞株杀伤作用的研究
引用本文:杨桂琴,孙立群,管国芳,辛丁. 抗人喉癌双功能抗体制备及对Hep-2细胞株杀伤作用的研究[J]. 中国耳鼻咽喉头颈外科, 2000, 7(3): 164-166
作者姓名:杨桂琴  孙立群  管国芳  辛丁
作者单位:130041,长春白求恩医科大学附属第二临床学院耳鼻咽喉-头颈外科;130041,长春白求恩医科大学附属第二临床学院耳鼻咽喉-头颈外科;130041,长春白求恩医科大学附属第二临床学院耳鼻咽喉-头颈外科;130041,长春白求恩医科大学附属第二临床学院耳鼻咽喉-头颈外科
基金项目:国家自然科学基金!39470747
摘    要:目的:为了制备高效的,特异的抗人喉癌/抗蓖麻毒素A双功能单克隆抗体,观察其对Hep-2细胞株杀伤作用。方法:选用BALB/C鼠,分别行蓖麻毒素A和人喉鳞状细胞癌腹腔免疫后,提取抗体,经与骨髓瘤细胞融合,制备成抗人喉癌/抗蓖麻毒素A双特异性单克隆抗体。结果:该双功能抗体与喉癌组织的特异性结合率为87%,对Hep-2细胞半数抑制浓度比游离环磷酰胺强40倍。结论:采用二次杂交瘤技术制备的双功能抗体优于化学偶联法,抗体效价具有均匀性和理想的信噪比,抗体易于标准化。

关 键 词:喉肿瘤(Laryngeal neoplasms)  癌(Carcinoma)  抗体  肿瘤(Antibodies  noplasm)
修稿时间:1999-11-22

Preparation of human laryngeal cancer bispecific antibody and its killing effect to Hep-2 cell line
Yang Guiqin,Sun Liqun,Guan Guofang,Xin Ding. Preparation of human laryngeal cancer bispecific antibody and its killing effect to Hep-2 cell line[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2000, 7(3): 164-166
Authors:Yang Guiqin  Sun Liqun  Guan Guofang  Xin Ding
Abstract:To investigate the preparation of a human laryngeal cancerbispecific antibody. Methods: The second set hybrid tumor technology was applied to prepare an anti-human laryngeal cancer and anti-castor toxin A bispecific monoclonal antibody. Results: The specific conjugation rate between bispecific monoclonal antibody and laryngeal cancer tissue was 87%. The half inhibition concentration to Hep-2 cell was 40 times stronger than that of free cyclophosphamide. Conclusion:The second set hybrid tumor technology to prepare the bispecific antibody had a homogeneous titer,an idealsignal-to-noise ratio and was easy to be standardized.
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号